Coop, one of Switzerland’s largest retail and wholesale companies, has tapped embedded finance fintech Additiv to launch its new financial services app Coop Finance+. With this new service, in collaboration with several partners in the financial, pension and technology sectors, Coop is the first company in the country to launch a new and completely digital solution for […]
Memo Therapeutics, a late-stage biotech firm specializing in top-tier therapeutic antibodies, disclosed the successful conclusion of its CHF 25 million Series C funding round. This milestone was spearheaded by Pureos Bioventures, with strong participation from Memo
Walder Wyss has acted as legal counsel to SkyCell on the completion of a USD 57 million equity financing round at a USD 600 million valuation with M&G Investments, a global investment firm that invests
Homburger acted as counsel to Elevate Textiles in connection with a term loan credit agreement with Wilmington Savings Funds Society, FSB as administrative agent and an asset-based loan credit agreement with Bank of America as
Homburger acted as counsel to UBS Switzerland in its capacity as mandated lead arranger, agent, security agent and lender in connection with ITS Kanal Services’s new CHF 123 million acquisition and working capital facilities. ITS
Homburger acted as counsel to the lenders represented by RBC Europe Limited in connection with the accession of EBD Irradiation Services, a company of the Ionisos group, to certain English law governed financing agreements relating
Niederer Kraft Frey has advised Zuger Kantonalbank as sole lender on an innovative CHF 24 million credit facility to finance Carvolution’s expansion of its modern vehicle fleet. Swiss start-up Carvolution is the market leader in
As we have informed here, PureGym has successfully completed the offering of GBP 805m (equivalent) senior secured notes and its GBP 175.5m revolving credit facility financing. The net proceeds of the notes will be used
Niederer Kraft Frey (‘NKF’) has provided legal counsel to Australia and New Zealand Banking Group Limited and The Hongkong and Shanghai Banking Corporation Limited, Singapore Branch, in their roles as sustainability coordinator and agent, respectively.
Vischer acted as legal advisor to LimmaTech Biologics as it successfully concluded a USD 37 million (CHF 33 million) Series A financing round, co-led by Adjuvant Capital, AXA IM Alts, and the Novo Holdings REPAIR Impact Fund.
